SSAAW
Science Strategic Acquisition Corp. Alpha [SSAAW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SSAAW Stock Summary
In the News
SSAAW Financial details
Company Rating
Neutral
Market Cap
0
Income
8.02B
Revenue
0
Book val./share
-0.4
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
20.52
Forward P/E
-
PEG
-
P/S
-
P/B
1.04
P/C
-
P/FCF
-
Quick Ratio
0.16
Current Ratio
0.21
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
574.39
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-42.42%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
5%
ROE
5%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.0E-4-6.0E-4
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
SSAAW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2020-12-31 | 2021-12-31 |
|---|---|---|---|
| 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | |
| Net income per share | 0 | 84.12 | |
| Operating cash flow per share | 0 | -34.28 | |
| Free cash flow per share | 0 | -34.28 | |
| Cash per share | 0 | 0.01 | |
| Book value per share | 0 | -0.52 | |
| Tangible book value per share | 0.52 | 7.48 | |
| Share holders equity per share | 0 | -0.52 | |
| Interest debt per share | 0 | -80.03 | |
| Market cap | 388.12M | 378.42M | |
| Enterprise value | 388.12M | 378.08M | |
| P/E ratio | 0 | 0.12 | |
| Price to sales ratio | 0 | 0 | |
| POCF ratio | 0 | -0.28 | |
| PFCF ratio | 0 | -0.28 | |
| P/B Ratio | 19.41K | -18.65 | |
| PTB ratio | 19.41K | -18.65 | |
| EV to sales | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 2.38 | |
| EV to operating cash flow | 0 | -0.28 | |
| EV to free cash flow | 0 | -0.28 | |
| Earnings yield | 0 | 8.63 | |
| Free cash flow yield | 0 | -3.52 | |
| Debt to equity | 0 | 0 | |
| Debt to assets | 0 | 0 | |
| Net debt to EBITDA | 0 | 0 | |
| Current ratio | 0 | 0.42 | |
| Interest coverage | 0 | 0.95 | |
| Income quality | 0 | -8.38 | |
| Dividend Yield | 0 | 0 | |
| Payout ratio | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | |
| Capex to revenue | 0 | 0 | |
| Capex to depreciation | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | |
| Graham number | 0 | 31.46 | |
| ROIC | 0 | 2.99K | |
| Return on tangible assets | 0 | 10.49 | |
| Graham Net | -4.74 | -0.53 | |
| Working capital | -183.91M | -952.21K | |
| Tangible asset value | 20M | 290.21M | |
| Net current asset value | -183.91M | -20.36M | |
| Invested capital | 0 | 0 | |
| Average receivables | 0 | 0 | |
| Average payables | 0 | 0 | |
| Average inventory | 0 | 0 | |
| Days sales outstanding | 0 | 0 | |
| Days payables outstanding | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | |
| Receivables turnover | 0 | 0 | |
| Payables turnover | 0 | 0 | |
| Inventory turnover | 0 | 0 | |
| ROE | 0 | -160.89 | |
| Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0.12 | 421.31 | 152.98 | 0.06 | 0.04 | |
| Operating cash flow per share | -0.16 | -0.17 | 0 | -0.02 | 0 | |
| Free cash flow per share | -0.16 | -0.17 | 0 | -0.02 | 0 | |
| Cash per share | 40.1 | 0.04 | 0.01 | 0.02 | 0.01 | |
| Book value per share | -2.83 | -2.61 | -0.5 | -0.44 | -0.4 | |
| Tangible book value per share | -2.83 | 37.39 | 9.5 | 9.56 | 9.6 | |
| Share holders equity per share | -2.83 | -2.61 | -0.5 | -0.44 | -0.4 | |
| Interest debt per share | 0 | -400.43 | 0 | 0 | 0 | |
| Market cap | 75.37M | 75.68M | 304.6M | 304.6M | 306.15M | |
| Enterprise value | 74.64M | 75.34M | 304.25M | 304.09M | 305.71M | |
| P/E ratio | 20.79 | 0.01 | 0.02 | 39.11 | 68.2 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -59.88 | -56.94 | 0 | -521.08 | -4.56K | |
| PFCF ratio | -59.88 | -56.94 | 0 | -521.08 | -4.56K | |
| P/B Ratio | -3.44 | -3.73 | -19.6 | -22.41 | -24.55 | |
| PTB ratio | -3.44 | -3.73 | -19.6 | -22.41 | -24.55 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 82.33 | 0.46 | 0.06 | 149.27 | 195.01 | |
| EV to operating cash flow | -59.29 | -56.68 | 0 | -520.2 | -4.56K | |
| EV to free cash flow | -59.29 | -56.68 | 0 | -520.2 | -4.56K | |
| Earnings yield | 0.01 | 43.21 | 15.59 | 0.01 | 0 | |
| Free cash flow yield | -0.02 | -0.02 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.81 | 0 | 0 | -0.25 | -0.28 | |
| Current ratio | 507.24 | 0.42 | 0.35 | 0.32 | 0.21 | |
| Interest coverage | 0 | 0.95 | 0 | 0 | 0 | |
| Income quality | -1.39 | -0.01 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.73 | 157.42 | 41.51 | 0.79 | 0.57 | |
| ROIC | 0.03 | 2.93K | -305.3 | 0.03 | -0.09 | |
| Return on tangible assets | 0.73 | 10.51 | 15.26 | 0.01 | 0 | |
| Graham Net | 37.11 | -2.67 | -0.51 | -0.45 | -0.45 | |
| Working capital | 310.66M | -952.21K | -1.24M | -1.58M | -2.14M | |
| Tangible asset value | -21.94M | 290.21M | 294.96M | 296.91M | 298.03M | |
| Net current asset value | 288.1M | -20.36M | -15.59M | -13.88M | -13.79M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.04 | -161.17 | -305.62 | -0.14 | -0.09 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
SSAAW Frequently Asked Questions
What is Science Strategic Acquisition Corp. Alpha stock symbol ?
Science Strategic Acquisition Corp. Alpha is a US stock , located in Santa monica of Ca and trading under the symbol SSAAW
What is Science Strategic Acquisition Corp. Alpha stock quote today ?
Science Strategic Acquisition Corp. Alpha stock price is $- today.
Is Science Strategic Acquisition Corp. Alpha stock public?
Yes, Science Strategic Acquisition Corp. Alpha is a publicly traded company.
Company Profile
- CEO Mr. Michael Gwynne Jones
- Headquarters Santa Monica,CA,US
- IPO Date 2021-03-18
Science Strategic Acquisition Corp. Alpha focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was founded in 2020 and is based in Santa Monica, California.
